Literature DB >> 24731571

Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma.

Claudia M Fischer1, Marian C Neidert2, Dominik Péus2, Nils H Ulrich3, Luca Regli2, Niklaus Krayenbühl2, Christoph M Woernle2.   

Abstract

OBJECTIVE: Glioblastomas are the most common primary malignant brain tumors in adults with a poor prognosis. The current study sought to identify risk factors in glioblastoma patients that are closely associated with communicating hydrocephalus.
METHODS: We retrospectively analyzed data from 151 patients who were diagnosed with a glioblastoma between 2007 and 2011 and underwent complete surgical resection closely followed by adjuvant radiochemotherapy.
RESULTS: We observed a significant tendency toward communicating hydrocephalus in cases of ventricular opening during surgical tumor resection (Fisher's exact test p<0.001) and a noticeable, although not statistically significant, correlation between the onset of communicating hydrocephalus and evidence of leptomeningeal tumor dissemination (Fisher's exact test p=0.067). Additionally, there was a trend toward frontal tumor location and a larger tumor volume in patients with communicating hydrocephalus. The majority of patients suffering from communicating hydrocephalus received a cerebrospinal fluid (CSF) shunt implantation after radiation therapy (63.6%, Fisher's exact test p=0.000).
CONCLUSION: We identified the following risk factors associated with the onset of communicating hydrocephalus in glioblastoma patients: ventricular opening during tumor resection and leptomeningeal tumor dissemination. Shunt implantation seems to be safe and effective in these patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glioblastoma; Hydrocephalus; Leptomeningeal tumor dissemination; Neurosurgery; Ventriculoperitoneal shunt

Mesh:

Year:  2014        PMID: 24731571     DOI: 10.1016/j.clineuro.2014.02.012

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

1.  The effect of tumor removal via craniotomies on preoperative hydrocephalus in adult patients with intracranial tumors.

Authors:  Sayied Abdol Mohieb Hosainey; Benjamin Lassen; John K Hald; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2018-08-17       Impact factor: 3.042

Review 2.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

3.  Leptomeningeal disease in glioblastoma: endgame or opportunity?

Authors:  Sarfraz Akmal; Elizabeth E Ginalis; Nitesh V Patel; Robert Aiken; Alis J Dicpinigaitis; Simon J Hanft
Journal:  J Neurooncol       Date:  2021-10-08       Impact factor: 4.130

4.  The safety profile of Tumor Treating Fields (TTFields) therapy in glioblastoma patients with ventriculoperitoneal shunts.

Authors:  Nancy Ann Oberheim-Bush; Wenyin Shi; Michael W McDermott; Alexander Grote; Julia Stindl; Leonardo Lustgarten
Journal:  J Neurooncol       Date:  2022-05-31       Impact factor: 4.506

5.  Comparative Analysis of Subventricular Zone Glioblastoma Contact and Ventricular Entry During Resection in Predicting Dissemination, Hydrocephalus, and Survival.

Authors:  Akshitkumar M Mistry; Patrick D Kelly; Jean-Nicolas Gallant; Nishit Mummareddy; Bret C Mobley; Reid C Thompson; Lola B Chambless
Journal:  Neurosurgery       Date:  2019-11-01       Impact factor: 4.654

6.  Risk factors for new-onset shunt-dependency after craniotomies for intracranial tumors in adult patients.

Authors:  Sayied Abdol Mohieb Hosainey; Benjamin Lassen; John K Hald; Eirik Helseth; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2017-07-03       Impact factor: 3.042

7.  Ventriculoperitoneal Shunting for Glioblastoma: Risk Factors, Indications, and Efficacy.

Authors:  Brandyn A Castro; Brandon S Imber; Rebecca Chen; Michael W McDermott; Manish K Aghi
Journal:  Neurosurgery       Date:  2017-03-01       Impact factor: 4.654

8.  Comparing Glioblastoma Surgery Decisions Between Teams Using Brain Maps of Tumor Locations, Biopsies, and Resections.

Authors:  Domenique M J Müller; Pierre A J T Robe; Roelant S Eijgelaar; Marnix G Witte; Martin Visser; Jan C de Munck; Marieke L D Broekman; Tatjana Seute; Jeroen Hendrikse; David P Noske; William P Vandertop; Frederik Barkhof; Mathilde C M Kouwenhoven; Emmanuel Mandonnet; Mitchel S Berger; Philip C De Witt Hamer
Journal:  JCO Clin Cancer Inform       Date:  2019-01

9.  Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

Authors:  Bujung Hong; Manolis Polemikos; Hans E Heissler; Christian Hartmann; Makoto Nakamura; Joachim K Krauss
Journal:  Fluids Barriers CNS       Date:  2018-06-04

10.  The Impact of Surgery on the Survival of Patients with Recurrent Glioblastoma.

Authors:  Oumar Sacko; Alexandra Benouaich-Amiel; Pierre Brandicourt; Mahamadou Niaré; Saloua Charni; Clarissa Cavandoli; David Brauge; Isabelle Catalaa; Adam Brenner; Elizabeth Cohen-Jonathan Moyal; Franck-Emmanuel Roux
Journal:  Asian J Neurosurg       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.